Effect of remazolam on inferior vena cava collapse index after general anesthesia induction

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2300070911

Enrollment

Unknown

Registered

2023-04-26

Start date

2023-05-01

Completion date

Unknown

Last updated

2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laryngeal mask for general anesthesia

Interventions

Experimental group:Remazolam induction

control group:Propofol induction

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: elective surgery;Laryngeal mask airway insertion; Aged 18-65 years old; ASA I or II

Exclusion criteria

Exclusion criteria: Body mass index = 30kg / m2 ; systolic blood pressure > 180mmHg, or < 90mmHg ; severe heart valve disease ; heart failure ; severe arrhythmia ; pregnant women ; laryngeal mask contraindications

Design outcomes

Primary

Measure	Time frame
Inferior vena cava collapse index after anesthesia induction;	—

Secondary

Measure	Time frame
Maximum diameter of inferior vena cava after induction of anesthesia;Minimum diameter of inferior vena cava after anesthesia induction;heart rate;mean arterial pressure;bispectral index;	—

Countries

China

Contacts

Public ContactHongbo Chen

Wenzhou People's Hospital

chenhongbo123@126.com+86 13587639921

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026